Literature DB >> 15957172

Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden.

Håkan Jonsson1, Robert Johansson, Per Lenner.   

Abstract

Screening with mammography has been shown to substantially reduce mortality from breast cancer. The incidence of invasive cancer will increase as screening starts, and it is desirable that it gradually returns to the same level as before screening. Age-specific incidence of invasive breast cancer in 11 Swedish counties, including 463,000 women aged 40-74 years, was analysed before and after the start of service screening with mammography. Incidence, as observed on average during 12.8 years from screening start, was compared to expected incidence based on the incidence during a 15-year period preceding screening start. The height of the incidence peak during the first screening round was increasing with increasing age, compatible with the accumulation in the population of slowly growing tumours by age. All analysed age groups showed an increased ratio between observed stabilised incidence 7-14 years after screening start and expected incidence. When relative risks were adjusted for lead time, the estimates were 1.54 (95% confidence interval [CI] 1.33-1.79) and 1.21 (95% CI 1.04-1.41) for the age groups 50-59 and 60-69 years, respectively. In the age groups 40-49 and 70-74, no change was observed. The findings were further confirmed by the observation of a disappearance in the screened population of the notch in the increasing trend of age-specific breast cancer incidence for the ages after menopause. This notch could indicate hormone-related retardation in tumour growth around menopause. It appears that many of these clinically insignificant, retarded tumours are detected with screening mammography. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Year:  2005        PMID: 15957172     DOI: 10.1002/ijc.21228

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Ramifications of screening for breast cancer: definition of overdiagnosis is confusing in follow-up of Malmö trial.

Authors:  Per-Henrik Zahl; Jan Maehlen
Journal:  BMJ       Date:  2006-03-25

2.  [Breast cancer screening].

Authors:  Andreu Segura
Journal:  Aten Primaria       Date:  2006-09-30       Impact factor: 1.137

3.  Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.

Authors:  Sophia Zackrisson; Ingvar Andersson; Lars Janzon; Jonas Manjer; Jens Peter Garne
Journal:  BMJ       Date:  2006-03-03

4.  Content of invitations for publicly funded screening mammography.

Authors:  Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  BMJ       Date:  2006-03-04

Review 5.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

6.  The overdiagnosis nightmare: a time for caution.

Authors:  Stefano Ciatto
Journal:  BMC Womens Health       Date:  2009-12-16       Impact factor: 2.809

7.  Overdiagnosis in organised mammography screening in Denmark. A comparative study.

Authors:  Karsten J Jørgensen; Per-Henrik Zahl; Peter C Gøtzsche
Journal:  BMC Womens Health       Date:  2009-12-22       Impact factor: 2.809

8.  Breast cancer incidence and overdiagnosis in Catalonia (Spain).

Authors:  Montserrat Martinez-Alonso; Ester Vilaprinyo; Rafael Marcos-Gragera; Montserrat Rue
Journal:  Breast Cancer Res       Date:  2010-08-03       Impact factor: 6.466

9.  Screening: is breast cancer overdiagnosed?

Authors:  Andrea Veronesi; Diego Serraino
Journal:  Nat Rev Clin Oncol       Date:  2009-12       Impact factor: 66.675

Review 10.  Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.

Authors:  Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  BMJ       Date:  2009-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.